| Vaccine developer: |
Pfizer |
Moderna |
AstraZeneca |
Johnson & Johnson |
| When approved/expected approval |
Dec. 11 |
Dec. 18 |
Could submit application for emergency situation use permission in late March. |
Sent application for emergency use permission on Feb. 5. |
| What percentage of people did it secure from getting infected in scientific studies? |
95% |
941% |
70% |
66% |
| How many shots do you require? |
Two doses, 3 weeks apart |
Two doses, 4 weeks apart |
2 dosages, a month apart |
One dose |
| What are the side effects? |
Fatigue, headache, chills, muscle pain, particularly after the second dosage. |
Fever, muscle aches, headaches lasting a few days. Impacts even worse after second dosage. |
Injection website discomfort, fever, muscle aches, headache. |
Not yet readily available. |
| The number of dosages will be offered, and when? |
50 million, starting Dec. 18; 1.3 billion in 2021. |
20 million, starting Dec. 21; 80 million for U.S. in 2021. |
3 billion prepared for 2021. |
Not yet available. |
| Who is it suggested for? |
Individuals 16 years and older. |
Individuals 18 years and older. |
Not yet offered. |
Not yet readily available. |
| What about pregnant females and nursing moms? |
Pregnant ladies or nursing mommies who desire the COVID-19 vaccine should get one, specialists say. |
There’s restricted data. Studies in rats who were vaccinated prior to and throughout pregnancy discovered no safety concerns. The CDC says pregnant females might pick to get the vaccine. |
Not yet readily available. |
Not yet readily available. |
| Exists anyone who should not get the vaccine? |
Individuals with a history of serious allergic reactions, anyone with a history of allergies to vaccine ingredients including polyethylene glycol, and anybody with a history of allergic reactions to polysorbate. |
People with a history of serious allergies, anybody with a history of allergic reactions to vaccine components consisting of polyethylene glycol, and anybody with a history of allergic reactions to polysorbate. |
Not yet offered. |
Not yet available. |
| Any considerable negative effects? |
50 cases of anaphylaxis in people who received the vaccine, mainly females.
4 cases of Bell’s palsy, a kind of momentary facial paralysis, reported in individuals who got the vaccine. This is not more than would be expected in the general population.
|
.
21 cases of anaphylaxis in people who received the vaccine, all in women.
Four cases of Bell’s palsy reported in the scientific trials consisting of 3 in the vaccine group, and 1 in the placebo group. This is not more than would be expected in the basic population.
|
.
Four overall serious side effects, including 2 cases of transverse myelitis. |
One person went to the hospital for fever related to the vaccine. 4 other severe cases were not connected to the vaccine. |
| What about individuals with lowered immune function? |
Ok for people whose immune function is decreased by HIV or immunosuppressing drugs if they have no other factors to prevent it. There is restricted security data in this group. |
Ok for individuals whose immune function is decreased by HIV or immunosuppressing drugs if they have no other factors to prevent it. There is restricted security data in this group. |
Not yet offered. |
Not yet readily available. |
| What about people with autoimmune diseases? |
No data are readily available on the safety or effectiveness of mRNA vaccines in people with autoimmune disease. Individuals with autoimmune conditions may still get the shots if they have no other factors to avoid vaccination. |
No information are readily available on the security or efficiency of mRNA vaccines in individuals with autoimmune illness. Individuals with autoimmune conditions may still get the shots if they have no other reasons to prevent vaccination. |
Not yet available. |
Not yet offered. |
| Is the vaccine safe for people with a history of Guillain-Barre Syndrome (GBS)? |
To date, no cases of GBS have been seen in people vaccinated for COVID-19 The CDC states a history of GBS is not a factor to prevent vaccination. |
To date, no cases of GBS have actually been seen in people immunized for COVID-19 The CDC says a history of GBS is not a factor to avoid vaccination. |
Not yet available. |
Not yet available. |
No comments:
Post a Comment